fluorouracil has been researched along with Vitiligo in 38 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current study showed that using micro-needling in conjunction with 5-FU could treat vitiligo patients more efficiently than tacrolimus monotherapy." | 9.69 | The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial. ( Hadibarhaghtalab, M; Hatami, M; Parvar, SY; Pazyar, N; Radmanesh, M; Yaghoobi, R, 2023) |
| "The aim of this trial was to evaluate the efficacy of Er:YAG laser as a supplementary medicine to topical 5FU and clobetasol in vitiligo patients." | 9.27 | Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol. ( Bafandeh, B; Bostakian, A; Faghihi, G; Hosseini, SM; Iraji, F; Jafari-Koshki, T; Mokhtari, F; Shahmoradi, Z, 2018) |
| "In 28 patients with vitiligo, 5% fluorouracil cream was applied daily to vitiliginous lesions under occlusive dressings, following an epidermal abrasion on the first day." | 9.05 | Topically administered fluorouracil in vitiligo. ( Hamada, T; Tsuji, T, 1983) |
| "5-Fluorouracil application after microneedling is effective in the treatment of vitiligo with 75% response, 60% patient satisfaction, and tolerable side effects." | 8.12 | The clinical and pathological effectiveness of microneedling and topical 5-fluorouracil in vitiligo treatment: An association with matrix metalloproteinase 2 immunohistochemical expression. ( Abdou, AG; Farag, AGA; Rashwan, M; Shehata, WA, 2022) |
| "Twenty-five patients with vitiligo were subjected to microneedling of 2 patches of vitiligo with dermapen, then application of 5-fluorouracil to 1 patch and tacrolimus on the other patch." | 7.88 | Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. ( Al-Saeid, H; Elgarhy, L; Ibrahim, Z; Mina, M, 2018) |
| "Forty vitiligo patches in 22 consecutive patients with resistant vitiligo presenting at a vitiligo clinic of a university teaching medical school in New Delhi, India, were treated with microdermabrasion followed by topical 5% 5-fluorouracil (5-FU)." | 7.77 | Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study. ( Chander, R; Garg, T; Jain, A, 2011) |
| "Vitiligo is a prevalent destructive melanocyte skin disease that negatively affects the patients' life in terms of self-esteem." | 7.01 | Effectiveness of dermabrasion plus 5-fluorouracil vs suction blister in treating vitiligo: A comparative study. ( Asilian, A; Iraji, F; Kazemipour, S; Mohaghegh, F; Mokhtari, F; Mozafarpoor, S; Shahmoradi, Z; Talakoub, M, 2021) |
| " The aim of this study was to evaluate and compare the therapeutic efficacy of dermabrasion, dermabrasion combined with 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in the management of localized stable vitiligo." | 6.73 | Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. ( Gupta, RR; Mahajan, BB; Ohri, A; Sethi, S, 2007) |
| "Vitiligo is one of the most challenging dermatological diseases with little improvement promises." | 5.91 | Efficacy and safety of micro-needling combined with topical 5-fluorouracil and excimer light vs. excimer light alone in treatment of non-segmental vitiligo: A comparative study. ( Abdelaleem, HL; Saad, MA; Tawfik, KM, 2023) |
| "The current study showed that using micro-needling in conjunction with 5-FU could treat vitiligo patients more efficiently than tacrolimus monotherapy." | 5.69 | The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial. ( Hadibarhaghtalab, M; Hatami, M; Parvar, SY; Pazyar, N; Radmanesh, M; Yaghoobi, R, 2023) |
| "Vitiligo is a skin disorder commonly acquired." | 5.56 | Clinical evaluation of the efficacy of trichloroacetic acid 70% after microneedling vs intradermal injection of 5-fluorouracil in the treatment of nonsegmental vitiligo; A prospective comparative study. ( Khater, M; Khattab, FM; Nasr, M; Salah, S, 2020) |
| "The aim of this trial was to evaluate the efficacy of Er:YAG laser as a supplementary medicine to topical 5FU and clobetasol in vitiligo patients." | 5.27 | Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol. ( Bafandeh, B; Bostakian, A; Faghihi, G; Hosseini, SM; Iraji, F; Jafari-Koshki, T; Mokhtari, F; Shahmoradi, Z, 2018) |
| "Twenty-five patients with vitiligo were subjected to microneedling of 2 patches of vitiligo with dermapen, then application of 5-fluorouracil to 1 patch and tacrolimus on the other patch." | 3.88 | Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. ( Al-Saeid, H; Elgarhy, L; Ibrahim, Z; Mina, M, 2018) |
| "Vitiligo was an autoimmune disease and some guidelines for the management of vitiligo encouraged the use of NB-UVB combination therapies to enhance repigmentation." | 3.01 | Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis. ( Chen, M; Liu, C; Wang, J; Wei, Y; Zhang, L; Zhu, B, 2023) |
| "Vitiligo is a prevalent destructive melanocyte skin disease that negatively affects the patients' life in terms of self-esteem." | 3.01 | Effectiveness of dermabrasion plus 5-fluorouracil vs suction blister in treating vitiligo: A comparative study. ( Asilian, A; Iraji, F; Kazemipour, S; Mohaghegh, F; Mokhtari, F; Mozafarpoor, S; Shahmoradi, Z; Talakoub, M, 2021) |
| " The aim of this study was to evaluate and compare the therapeutic efficacy of dermabrasion, dermabrasion combined with 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in the management of localized stable vitiligo." | 2.73 | Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. ( Gupta, RR; Mahajan, BB; Ohri, A; Sethi, S, 2007) |
| "Vitiligo is one of the most challenging dermatological diseases with little improvement promises." | 1.91 | Efficacy and safety of micro-needling combined with topical 5-fluorouracil and excimer light vs. excimer light alone in treatment of non-segmental vitiligo: A comparative study. ( Abdelaleem, HL; Saad, MA; Tawfik, KM, 2023) |
| "Acral lesions of vitiligo are most likely recalcitrant to the known lines of treatment." | 1.72 | Efficacy and safety of combined fractional ablative CO ( Abdelhamid, MF; El Desouky, ED; Ramez, SA; Sayed, KS; Weshahy, R, 2022) |
| "Acral vitiligo is often resistant to medical and surgical treatments." | 1.72 | Microneedling and 5-flurouracil can enhance the efficacy of non-cultured epidermal cell suspension transplantation for resistant acral vitiligo. ( Albalat, W; Ehab, R; Elsayed, M; Fawzy, M; Salem, A, 2022) |
| "To evaluate the efficacy and safety of intradermal injection of 5-flurouracil (5-FU) combined with narrow-band ultraviolet B (NB-UVB) as a treatment option for vitiligo." | 1.38 | Treatment of localized non-segmental vitiligo with intradermal 5-flurouracil injection combined with narrow-band ultraviolet B: a preliminary study. ( Abd El-Samad, Z; Shaaban, D, 2012) |
| "Vitiligo is a disease of unknown origin that causes destruction of melanocytes in the skin, mucous membranes, the eyes, and occasionally in hairbulbs and in the ears." | 1.29 | Management of vitiligo. ( Grimes, P; Halder, RM; Nordlund, JJ, 1993) |
| "Vitiligo is characterized by depigmentation in large or small areas of the skin." | 1.27 | Vitiligo. ( Dunn, JF, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.16) | 18.7374 |
| 1990's | 2 (5.26) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 10 (26.32) | 24.3611 |
| 2020's | 14 (36.84) | 2.80 |
| Authors | Studies |
|---|---|
| Nofal, A | 1 |
| Eldeeb, F | 1 |
| Shalaby, M | 1 |
| Al-Balat, W | 1 |
| Elgarhy, LH | 1 |
| El-Tatawy, RA | 2 |
| Ali, DM | 1 |
| Anber, DM | 1 |
| Iskandarani, YA | 1 |
| Ismail, MA | 2 |
| Weshahy, R | 1 |
| Abdelhamid, MF | 1 |
| Sayed, KS | 1 |
| El Desouky, ED | 1 |
| Ramez, SA | 1 |
| Albalat, W | 1 |
| Elsayed, M | 1 |
| Salem, A | 1 |
| Ehab, R | 1 |
| Fawzy, M | 1 |
| Saad, MA | 1 |
| Tawfik, KM | 1 |
| Abdelaleem, HL | 1 |
| Zhu, B | 3 |
| Liu, C | 3 |
| Zhang, L | 3 |
| Wang, J | 3 |
| Chen, M | 3 |
| Wei, Y | 3 |
| Pazyar, N | 1 |
| Hatami, M | 1 |
| Yaghoobi, R | 1 |
| Parvar, SY | 1 |
| Radmanesh, M | 1 |
| Hadibarhaghtalab, M | 1 |
| Attwa, EM | 1 |
| Khashaba, SA | 1 |
| Ezzat, NA | 1 |
| Doghaim, NN | 1 |
| Ali, DAM | 1 |
| El Attar, YA | 1 |
| Khater, M | 1 |
| Nasr, M | 1 |
| Salah, S | 1 |
| Khattab, FM | 1 |
| Marasca, C | 1 |
| Fabbrocini, G | 1 |
| D'Andrea, M | 1 |
| Luciano, MA | 1 |
| De Maio, G | 1 |
| Ruggiero, A | 1 |
| Asilian, A | 1 |
| Kazemipour, S | 1 |
| Mokhtari, F | 2 |
| Iraji, F | 2 |
| Shahmoradi, Z | 2 |
| Mohaghegh, F | 1 |
| Mozafarpoor, S | 1 |
| Talakoub, M | 1 |
| Abdou, AG | 1 |
| Farag, AGA | 1 |
| Rashwan, M | 1 |
| Shehata, WA | 1 |
| Nordlund, JJ | 2 |
| Bostakian, A | 1 |
| Jafari-Koshki, T | 1 |
| Faghihi, G | 1 |
| Hosseini, SM | 1 |
| Bafandeh, B | 1 |
| Wenande, E | 1 |
| Erlendsson, AM | 1 |
| Haedersdal, M | 1 |
| Mina, M | 1 |
| Elgarhy, L | 1 |
| Al-Saeid, H | 1 |
| Ibrahim, Z | 1 |
| King, YA | 1 |
| Tsai, TY | 1 |
| Tsai, HH | 1 |
| Huang, YC | 1 |
| Jha, AK | 1 |
| Sonthalia, S | 1 |
| Kumar, A | 1 |
| Bharti, R | 1 |
| Agarwal, S | 1 |
| Andrade Lima, EV | 1 |
| Aandrade Lima, MMD | 1 |
| Miot, HA | 1 |
| Mohamed, HA | 1 |
| Mohammed, GF | 1 |
| Gomaa, AH | 1 |
| Eyada, MM | 1 |
| Anbar, TS | 1 |
| Westerhof, W | 2 |
| Abdel-Rahman, AT | 1 |
| Ewis, AA | 1 |
| El-Khayyat, MA | 1 |
| Naldi, L | 1 |
| Sassi, F | 1 |
| Moore, AY | 1 |
| Abd El-Samad, Z | 1 |
| Shaaban, D | 1 |
| Garg, T | 1 |
| Chander, R | 1 |
| Jain, A | 1 |
| Anbar, T | 1 |
| Abdel-Rahman, A | 1 |
| El-Khayyat, M | 1 |
| El-Metwally, Y | 1 |
| Sethi, S | 1 |
| Mahajan, BB | 1 |
| Gupta, RR | 1 |
| Ohri, A | 1 |
| Tavares-Bello, R | 1 |
| Tsuji, T | 1 |
| Hamada, T | 1 |
| Dippel, E | 1 |
| Haas, N | 1 |
| Czarnetzki, BM | 1 |
| Halder, RM | 1 |
| Grimes, P | 1 |
| Schmid-Wendtner, MH | 1 |
| Wendtner, CM | 1 |
| Volkenandt, M | 1 |
| Heinemann, V | 1 |
| Rees, RB | 1 |
| Dunn, JF | 1 |
| Monk, B | 1 |
| Szekeres, E | 1 |
| Morvay, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo[NCT05008887] | Phase 4 | 50 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | ||
| Efficacy of Topical 5-fluorouracil Versus Topical Latanoprost With Microneedling in Localized Stable Vitiligo: A Randomised Clinical Trial[NCT05513924] | Phase 2/Phase 3 | 40 participants (Actual) | Interventional | 2022-03-15 | Completed | ||
| Phase I, Dual Arm, Open-Label, Trial of Intralesional 5-Fluorouracil (5FU) and Intralesional 5FU Combined With Topical Imiquimod in Patients With Squamous Cell Carcinoma (SCC) of the Lower Extremities[NCT03370406] | Phase 1 | 30 participants (Anticipated) | Interventional | 2018-08-03 | Recruiting | ||
| Fractional Laser Abrasion in Combination With UVB Therapy in Vitiligo Patients: a Randomized Controlled Study.[NCT02290717] | 0 participants (Actual) | Interventional | 2015-05-31 | Withdrawn (stopped due to Difficulty including patients) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for fluorouracil and Vitiligo
| Article | Year |
|---|---|
Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Network Meta-Analysis; Treatment Outcome; Ultraviol | 2023 |
Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Network Meta-Analysis; Treatment Outcome; Ultraviol | 2023 |
Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Network Meta-Analysis; Treatment Outcome; Ultraviol | 2023 |
Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Network Meta-Analysis; Treatment Outcome; Ultraviol | 2023 |
The Medical Treatment of Vitiligo: An Historical Review.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anthelmintics; Antimalarials; Antimetabolites, A | 2017 |
Opportunities for laser-assisted drug delivery in the treatment of cutaneous disorders.
Topics: Administration, Cutaneous; Anesthetics, Local; Antineoplastic Agents; Cicatrix; Cosmetic Techniques; | 2017 |
The efficacy of ablation-based combination therapy for vitiligo: A systematic review and meta-analysis.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Combined Modality Therapy; Dermabrasion; Fluorourac | 2018 |
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic | 2009 |
Newer treatment in dermatology.
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Antifungal Agents; Antineoplastic Agents; Carotenoids; Derma | 1975 |
11 trials available for fluorouracil and Vitiligo
| Article | Year |
|---|---|
Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: A comparative study.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Tacrolimus; Treatment Outcome; Trichloroacetic Acid | 2022 |
The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial.
Topics: Fluorouracil; Humans; Immunosuppressive Agents; Ointments; Tacrolimus; Treatment Outcome; Vitiligo | 2023 |
Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Child; Combined Modality Therapy; Dry Needling; | 2020 |
Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Child; Combined Modality Therapy; Dermabrasion; Female | 2020 |
Effectiveness of dermabrasion plus 5-fluorouracil vs suction blister in treating vitiligo: A comparative study.
Topics: Blister; Dermabrasion; Fluorouracil; Humans; Skin Pigmentation; Suction; Treatment Outcome; Vitiligo | 2021 |
Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Clobetasol; Combined Modality Therapy; F | 2018 |
Carbon dioxide laser plus topical 5-fluorouracil: a new combination therapeutic modality for acral vitiligo.
Topics: Adult; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Humans; Lasers, Gas; Low-Le | 2015 |
Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study.
Topics: Administration, Topical; Fluorouracil; Humans; Laser Therapy; Time Factors; Treatment Outcome; Vitil | 2008 |
Treatment of periungual vitiligo with erbium-YAG-laser plus 5-flurouracil: a left to right comparative study.
Topics: Adolescent; Adult; Antimetabolites; Combined Modality Therapy; Female; Fingers; Fluorouracil; Humans | 2006 |
Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo.
Topics: Administration, Topical; Adult; Cicatrix, Hypertrophic; Combined Modality Therapy; Dermabrasion; Der | 2007 |
Topically administered fluorouracil in vitiligo.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Dermabrasion; Female; Fluorouracil; Humans; | 1983 |
21 other studies available for fluorouracil and Vitiligo
| Article | Year |
|---|---|
Treatment of stable nonsegmental vitiligo using transdermal delivery of 5-fluorouracil by fractional CO
Topics: Carbon Dioxide; Combined Modality Therapy; Fluorouracil; Humans; Injections, Intralesional; Prospect | 2022 |
Efficacy and safety of combined fractional ablative CO
Topics: Carbon Dioxide; Combined Modality Therapy; Fluorouracil; Humans; Lasers, Gas; Treatment Outcome; Ult | 2022 |
Microneedling and 5-flurouracil can enhance the efficacy of non-cultured epidermal cell suspension transplantation for resistant acral vitiligo.
Topics: Fluorouracil; Humans; Melanocytes; Skin Pigmentation; Transplantation, Autologous; Treatment Outcome | 2022 |
Efficacy and safety of micro-needling combined with topical 5-fluorouracil and excimer light vs. excimer light alone in treatment of non-segmental vitiligo: A comparative study.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Hypopigmentation; Pigmentation Disorders; Treatment | 2023 |
Clinical evaluation of the efficacy of trichloroacetic acid 70% after microneedling vs intradermal injection of 5-fluorouracil in the treatment of nonsegmental vitiligo; A prospective comparative study.
Topics: Administration, Cutaneous; Combined Modality Therapy; Fluorouracil; Humans; Injections, Intradermal; | 2020 |
Low dose oral corticosteroids, microneedling, and topical 5-fluorouracil: A novel treatment for recalcitrant pediatric vitiligo.
Topics: Adrenal Cortex Hormones; Child; Fluorouracil; Humans; Male; Skin Pigmentation; Treatment Outcome; Vi | 2021 |
The clinical and pathological effectiveness of microneedling and topical 5-fluorouracil in vitiligo treatment: An association with matrix metalloproteinase 2 immunohistochemical expression.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Matrix Metalloproteinase 2; Treatment Outcome; Viti | 2022 |
Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo.
Topics: Administration, Cutaneous; Cosmetic Techniques; Dermatologic Agents; Female; Fluorouracil; Humans; H | 2018 |
5-Fluorouracil as an adjuvant therapy along with microneedling in vitiligo.
Topics: Chemotherapy, Adjuvant; Cosmetic Techniques; Fluorouracil; Humans; Immunosuppressive Agents; Needles | 2019 |
Microneedling with Dermaroller 192 needles along with 5-fluorouracil solution in the treatment of stable vitiligo.
Topics: Administration, Cutaneous; Cosmetic Techniques; Female; Fluorouracil; Humans; Needles; Patient Satis | 2019 |
Induction of Pigmentation Through Microneedling in Stable Localized Vitiligo Patients.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Adult; Brazil; Combined Modality The | 2020 |
Vitiligo.
Topics: Administration, Cutaneous; Combined Modality Therapy; Dermatologic Agents; Fluorouracil; Humans; Hyd | 2009 |
Treatment of localized non-segmental vitiligo with intradermal 5-flurouracil injection combined with narrow-band ultraviolet B: a preliminary study.
Topics: Adolescent; Adult; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunosuppressive Agents | 2012 |
Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study.
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Dermabrasion; Female; Fluorouracil; Humans; Ind | 2011 |
Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; | 2007 |
Porokeratosis of Mibelli associated with active chronic hepatitis and vitiligo.
Topics: Female; Fluorouracil; Hepatitis, Chronic; Humans; Leg Dermatoses; Middle Aged; Porokeratosis; Vitili | 1994 |
Management of vitiligo.
Topics: Administration, Cutaneous; Adolescent; Adult; Child; Dermabrasion; Drugs, Chinese Herbal; Female; Fl | 1993 |
Clinical picture: leopard-like vitiligo with capecitabine.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil | 2001 |
Vitiligo.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl | 1986 |
Topical fluorouracil in vitiligo.
Topics: Administration, Topical; Fluorouracil; Humans; Ointments; Racial Groups; Vitiligo | 1985 |
Repigmentation of vitiligo macules treated topically with Efudix cream.
Topics: Administration, Topical; Adult; Child; Female; Fluorouracil; Humans; Male; Melanocytes; Microscopy, | 1985 |